Oxamniquine FDA Link

An anthelmintic with schistosomicidal activity against Schistosoma mansoni, but not against other Schistosoma spp. Oxamniquine causes worms to shift from the mesenteric veins to the liver where the male worms are retained; the female worms return to the mesentery, but can no longer release eggs. (From Martindale, The Extra Pharmacopoeia, 31st ed, p121)

Also Known As:

Oxaminiquine; UK-4271; UK 4271; UK4271; 6-Quinolinemethanol, 1,2,3,4- tetrahydro- 2- (((1- methylethyl)amino)methyl)- 7- nitro-

Pharmalogical Action Categories:

Schistosomicides

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Hydroxyquinolines: 9
        Oxamniquine: 195
      - Nitroquinolines: 2
        Oxamniquine: 195

Horácio Manuel Santana Teles Selected Research

Horácio Manuel Santana Teles Research Topics

Disease

Drug/Important Bio-Agent (IBA)